companydata.dkAbacus Medicine Pharmaceuticals ApS: Financial statements 2023
CVR: 39192063
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -72,855 and a net result of DKK 1,385,541 compared with DKK -4,553,460 the year before. Equity amounted to DKK 22,182,951. The solvency ratio was 17.4%.
- Gross Profit
- -72,855 kr.
- Profit/Loss
- 1,385,541 kr.
- Equity
- 22,182,951 kr.
- Total Assets
- 127,181,357 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -73 t. | 1.4 mio. | 22.2 mio. | 0 |
| 2022 | - | -36 t. | -4.6 mio. | 20.8 mio. | 0 |
| 2021 | - | -43 t. | 2.8 mio. | 25.4 mio. | 0 |
| 2020 | - | -63 t. | 188 t. | 22.6 mio. | 0 |
| 2019 | - | -212 t. | 548 t. | 15.9 mio. | 0 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Abacus Medicine Pharmaceuticals ApS has published its annual report for 2022. Gross profit came to DKK -36,339, and the net result was DKK -4,553,460.
About Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity amounted to DKK 14,264,000.